within Pharmacolibrary.Drugs.ATC.M;

model M01AH05
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.83,
    Cl             = 50 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 120 / 1000000,
    adminCount     = 1,
    Vd             = 0.12,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.009583333333333333,
    Tlag           = 10.200000000000001
  );

  annotation(Documentation(
    info ="<html><body><p>Etoricoxib is a selective COX-2 inhibitor nonsteroidal anti-inflammatory drug (NSAID) used primarily for the treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, gout, and pain management. It is approved for use in several countries but not in the United States.</p><h4>Pharmacokinetics</h4><p>Healthy adult volunteers, both sexes, after oral single dose administration.</p><h4>References</h4><ol><li><p>Schwartz, J, et al., &amp; Agrawal, N (2009). The effect of etoricoxib on the pharmacokinetics of oral contraceptives in healthy participants. <i>Journal of clinical pharmacology</i> 49(7) 807–815. DOI:<a href=&quot;https://doi.org/10.1177/0091270009337131&quot;>10.1177/0091270009337131</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/19443681/&quot;>https://pubmed.ncbi.nlm.nih.gov/19443681</a></p></li><li><p>Hynninen, VV, et al., &amp; Laine, K (2009). Oral voriconazole and miconazole oral gel produce comparable effects on the pharmacokinetics and pharmacodynamics of etoricoxib. <i>European journal of clinical pharmacology</i> 65(1) 89–95. DOI:<a href=&quot;https://doi.org/10.1007/s00228-008-0556-9&quot;>10.1007/s00228-008-0556-9</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18777173/&quot;>https://pubmed.ncbi.nlm.nih.gov/18777173</a></p></li><li><p>Schwartz, JI, et al., &amp; Gottesdiener, K (2009). Examination of the effect of increasing doses of etoricoxib on oral methotrexate pharmacokinetics in patients with rheumatoid arthritis. <i>Journal of clinical pharmacology</i> 49(10) 1202–1209. DOI:<a href=&quot;https://doi.org/10.1177/0091270009338939&quot;>10.1177/0091270009338939</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/19783714/&quot;>https://pubmed.ncbi.nlm.nih.gov/19783714</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end M01AH05;
